Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

The negative component in schizophrenia

¹Psychiatrische Klinik und Poliklinik, Ludwig Maximilians Universität, Munich, Germany.

Acta Psychiatrica Scandinavica. Supplementum

|January 1, 1995

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Correction: Non-Response to Antidepressants: Risk Factors and Therapeutic Possibilities.

Pharmacopsychiatry·2026

Same author

Vagal Nerve Stimulation-Modulation of the Anti-Inflammatory Response and Clinical Outcome in Psoriatic Arthritis or Ankylosing Spondylitis.

Mediators of inflammation·2021

Same author

The role of interleukin-18 in the diagnosis and monitoring of hemophagocytic lymphohistiocytosis/macrophage activation syndrome - a systematic review.

Clinical and experimental immunology·2020

Same author

Short-term transcutaneous non-invasive vagus nerve stimulation may reduce disease activity and pro-inflammatory cytokines in rheumatoid arthritis: results of a pilot study.

Scandinavian journal of rheumatology·2020

Same author

Soluble CD163 and soluble mannose receptor predict survival and decompensation in patients with liver cirrhosis, and correlate with gut permeability and bacterial translocation.

Alimentary pharmacology & therapeutics·2017

Same author

Letter: autoimmune hepatitis-drug-induced liver injury must always be excluded. Authors' reply.

Alimentary pharmacology & therapeutics·2017

Same journal

Use of psychotropic drugs during pregnancy and breast-feeding.

Acta psychiatrica Scandinavica. Supplementum·2015

Same journal

Getting depression clinical practice guidelines right: time for change?

Acta psychiatrica Scandinavica. Supplementum·2013

Same journal

Manipulating melatonin in managing mood.

Acta psychiatrica Scandinavica. Supplementum·2013

Same journal

Chronobiology of mood disorders.

Acta psychiatrica Scandinavica. Supplementum·2013

Same journal

It is time we managed depression: the emerging role of chronobiology. Preface.

Acta psychiatrica Scandinavica. Supplementum·2013

Same journal

Lifestyle management of unipolar depression.

Acta psychiatrica Scandinavica. Supplementum·2013

See all related articles

Conflicting results on drug efficacy for negative symptoms stem from varied definitions and secondary causes. Path analysis indicates risperidone has a direct beneficial effect on negative symptoms, beyond its impact on positive symptoms and side effects.

Area of Science:

Psychiatry
Pharmacology
Clinical Research

Background:

Discrepancies in the literature regarding the efficacy of antipsychotic medications for negative symptoms are common.
These conflicts often stem from the use of diverse definitions for negative symptoms and the potential for secondary causes like depression or drug side effects.

Purpose of the Study:

To clarify the direct versus indirect effects of medications on negative symptoms.
To analyze the specific contribution of risperidone's direct effects on negative symptoms in a clinical trial setting.

Main Methods:

Review of literature addressing definitions and confounding factors in negative symptom research.
Application of path analysis to data from a North American clinical trial comparing risperidone and haloperidol.

Related Experiment Videos

Statistical methods including analyses of covariance and regression analyses were considered.

Main Results:

Path analysis of risperidone trial data suggests a direct beneficial effect on negative symptoms.
This direct effect is independent of risperidone's impact on positive symptoms and its favorable side-effect profile compared to haloperidol.
Broader definitions of negative symptoms correlate with perceived drug efficacy, while narrow definitions suggest limited drug effects.

Conclusions:

The direct effects of antipsychotic medications on negative symptoms can be elucidated through advanced statistical modeling.
Future clinical trial designs should prioritize methods to better isolate and measure these direct drug effects.
Risperidone demonstrates a direct positive impact on negative symptoms, contributing to its overall therapeutic benefit.